BusinessTelix Pharmaceuticals Limited Lists on the Australian Securities ExchangeBy Nasdaq OMXNov 15, 2017, 1:00 AM UTC
BusinessTelix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public OfferingBy Nasdaq OMXNov 8, 2017, 11:20 PM UTC
BusinessKevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals LimitedBy Nasdaq OMXSep 17, 2017, 10:00 PM UTC
